Starpharma’s Antibiotic-Free BV Gel Launched In The UK
Australian sexual health specialist Starpharma launches its innovative, antibiotic-free Viva Gel BV bacterial vaginosis treatment in the UK.
You may also be interested in...
Scynexis highlights enrollment exceeding expectations in Phase III VVC trials; Daré prepares to enter Phase III to treat BV.
Starpharma has received approval for its innovative VivaGel condom in Japan, which will be launched in the first half of 2019 by Okamoto Industries.
Essity has launched in the UK an Issviva branded e-commerce platform and dietary supplements range and two sustainable plaster additions to the Leukoplast wound-care line.